In syndromic cases, the morphology of the tumor(s), molecular immunohistochemistry (e.g., PTEN, beta-catenin, SDHB), the findings in the non-tumorous thyroid parenchyma, and other associated lesions may provide insight into the underlying disorder. This evidence concerns the gene PTEN and neoplasm.